ESC Professional Premium Access

What you need to know about antithrombotic therapy in patients after TAVI

Event: ESC Congress 2022
Topic: Clinical
Session type: Symposium
Date: 28 August 2022
Time: 08:30 - 10:00

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

5 presentations in this session

Embolic stroke. Ischaemic and bleeding risk in patients undergoing TAVI.

Speaker: Professor D. Capodanno (Catania, IT)
Thumbnail

Antithrombotic therapy in TAVI patients without indication for oral anticoagulation.

Speaker: Professor G. Dangas (New York, US)
Thumbnail

Antithrombotic therapy in TAVI patients with indication for oral anticoagulation.

Speaker: Professor M. Valgimigli (Lugano, CH)
Thumbnail

Antithrombotic therapy during TAVI and peri-interventional management of antithrombotic therapy.

Speaker: Doctor M. Joner (Munich, DE)
Thumbnail

What you need to know about antithrombotic therapy in patients after TAVI – discussion.

Thumbnail

4 speakers from this session

Professor Davide Capodanno

University of Catania, Catania (Italy)
27 presentations
5 followers

Professor George Dangas

Mount Sinai Medical Center, New York (United States of America)
12 presentations
0 follower

Professor Marco Valgimigli

Cardiocentro Ticino Foundation, Lugano (Switzerland)
22 presentations
1 follower

Doctor Michael Joner

German Heart Center of Munich, Munich (Germany)
7 presentations
0 follower

This platform is supported by

logo Novo Nordisk